Clinical Trials · NCT07881458
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Eli Lilly and Company
- Enrollment
- 1,000
- Start date
- Nov 2026
- Locations
- 75 sites, 10 countries
- Primary endpoint
- Percent Change from Baseline in Body Weight